Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by KBC Group NV

KBC Group NV lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 383,494 shares of the medical equipment provider's stock after selling 40,010 shares during the quarter. Intuitive Surgical makes up 0.6% of KBC Group NV's investment portfolio, making the stock its 28th largest position. KBC Group NV owned about 0.11% of Intuitive Surgical worth $189,934,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Atala Financial Inc bought a new stake in Intuitive Surgical in the fourth quarter valued at approximately $25,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $26,000. Global Financial Private Client LLC grew its holdings in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the last quarter. Hurley Capital LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Finally, Summit Securities Group LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $30,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $5.61 during mid-day trading on Monday, hitting $539.32. The stock had a trading volume of 292,939 shares, compared to its average volume of 1,989,084. The firm's 50 day moving average is $532.08 and its 200 day moving average is $536.70. The stock has a market capitalization of $193.30 billion, a price-to-earnings ratio of 79.04, a PEG ratio of 5.66 and a beta of 1.67. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period last year, the business earned $1.50 earnings per share. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the company's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Gary Loeb sold 1,700 shares of the stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president now directly owns 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock worth $2,611,577 in the last quarter. Company insiders own 0.70% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ISRG shares. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Royal Bank Of Canada lowered their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Evercore ISI dropped their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. Piper Sandler lowered their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Finally, Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.